Access the full text.
Sign up today, get DeepDyve free for 14 days.
A. El-Naggar, J. Chan, J. Grandis, 高田 隆, P. Slootweg (2017)
WHO classification of head and neck tumours
F. Lecaille, J. Kaleta, D. Brömme (2002)
Human and parasitic papain-like cysteine proteases: their role in physiology and pathology and recent developments in inhibitor design.Chemical reviews, 102 12
F. Matos, Maiara Moraes, Emília Silva, H. Galvão, R. Freitas (2013)
Immunohistochemical detection of receptor activator nuclear κB ligand and osteoprotegerin in odontogenic cysts and tumors.Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 71 11
O. Kudo, A. Sabokbar, A. Pocock, I. Itonaga, Y. Fujikawa, N. Athanasou (2002)
Interleukin-6 and interleukin-11 support human osteoclast formation by a RANKL-independent mechanism.Bone, 32 1
C. Bosio, G. Felippe, E. Bortoluzzi, M. Felippe, W. Felippe, E. Rivero (2014)
Subcutaneous connective tissue reactions to iRoot SP, mineral trioxide aggregate (MTA) Fillapex, DiaRoot BioAggregate and MTA.International endodontic journal, 47 7
L. Martin, P. Speight (2017)
Odontogenic cysts: an updateDiagnostic Histopathology, 23
H. Yasuda, N. Shima, N. Nakagawa, K. Yamaguchi, M. Kinosaki, S. Mochizuki, Akihiro Tomoyasu, K. Yano, M. Goto, A. Murakami, E. Tsuda, T. Morinaga, K. Higashio, N. Udagawa, N. Takahashi, T. Suda (1998)
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL.Proceedings of the National Academy of Sciences of the United States of America, 95 7
K. Riden, Present address (1998)
CLASSIFICATION OF HEAD AND NECK TUMOURS
Maiara Moraes, H. Lucena, P. Azevedo, L. Queiroz, A. Costa (2011)
Comparative immunohistochemical expression of RANK, RANKL and OPG in radicular and dentigerous cysts.Archives of oral biology, 56 11
K. Matsuo, N. Irie (2008)
Osteoclast-osteoblast communication.Archives of biochemistry and biophysics, 473 2
K. Adkison, D. Barrett, D. Deaton, R. Gampe, A. Hassell, S. Long, R. McFadyen, Aaron Miller, L. Miller, J. Payne, L. Shewchuk, K. Wells-Knecht, D. Willard, L. Wright (2006)
Semicarbazone-based inhibitors of cathepsin K, are they prodrugs for aldehyde inhibitors?Bioorganic & medicinal chemistry letters, 16 4
(2006)
Receptor activator NFκB-ligand and osteoprotegerin protein expression in human periapical cysts and granulomas. Oral Surg Oral Med Oral Pathol Oral Radiol Endod
N. Nakagawa, M. Kinosaki, K. Yamaguchi, N. Shima, H. Yasuda, K. Yano, T. Morinaga, K. Higashio (1998)
RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis.Biochemical and biophysical research communications, 253 2
X. Wen, L. Yi, F. Liu, J. Wei, Y. Xue (2016)
The role of cathepsin K in oral and maxillofacial disorders.Oral diseases, 22 2
Guoyin Liu, Naicheng Liu, Yuansheng Xu, Y. Ti, Jiangning Chen, Jianmin Chen, Junfeng Zhang, Jianning Zhao (2015)
Endoplasmic reticulum stress-mediated inflammatory signaling pathways within the osteolytic periosteum and interface membrane in particle-induced osteolysisCell and Tissue Research, 363
C. Gardner (2007)
Comparison of morphological effects of PGE2 and TGFβ on osteoclastogenesis induced by RANKL in mouse bone marrow cell culturesCell and Tissue Research, 330
S. Santos, L. Couto, J. Fonsêca, F. Xavier, A. Figueiredo, V. Freitas, R. Freitas, J. Santos, Á. Henriques (2017)
Participation of osteoclastogenic factors in immunopathogenesis of human chronic periapical lesionsJournal of Oral Pathology & Medicine, 46
E. Odell (2008)
Cysts of the oral and maxillofacial regionsHistopathology, 53
M. Shear, P. Speight (2008)
Radicular Cyst and Residual Cyst
B. Şengüven, T. Oygür (2011)
Investigation of interleukin-1 alpha and interleukin-6 expression and interleukin-1 alpha gene polymorphism in keratocystic odontogenic tumors and ameloblastomas.Medicina oral, patologia oral y cirugia bucal, 16 4
M. Tekkeşin, S. Mutlu, V. Olgaç (2011)
The Role of RANK/RANKL/OPG Signalling Pathways in Osteoclastogenesis in Odontogenic Keratocysts, Radicular Cysts, and AmeloblastomasHead and Neck Pathology, 5
B. Boyce, L. Xing (2008)
Functions of RANKL/RANK/OPG in bone modeling and remodeling.Archives of biochemistry and biophysics, 473 2
Bubacar Embaló, H. Parize, E. Rivero (2018)
Evaluation of cell proliferation in cystic lesions associated with impacted third molarsMicroscopy Research and Technique, 81
J. Servato, P. Prieto-Oliveira, P. Faria, A. Loyola, S. Cardoso (2013)
Odontogenic tumours: 240 cases diagnosed over 31 years at a Brazilian university and a review of international literature.International journal of oral and maxillofacial surgery, 42 2
F. Andrade, Débora Sousa, E. Mendonça, T. Silva, V. Lara, A. Batista (2008)
Expression of bone resorption regulators (RANK, RANKL, and OPG) in odontogenic tumors.Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 106 4
B. Troen (2006)
The Regulation of Cathepsin K Gene ExpressionAnnals of the New York Academy of Sciences, 1068
Andrew Mcclary, R. West, Ashley Mcclary, J. Pollack, N. Fischbein, bullet Christopher, F. Holsinger, John bullet, Sunwoo, bullet Colevas, bullet Davud, Sirjani (2016)
Ameloblastoma: a clinical review and trends in managementEuropean Archives of Oto-Rhino-Laryngology, 273
T. Silva, A. Batista, E. Mendonça, C. Leles, S. Fukada, F. Cunha (2008)
Comparative expression of RANK, RANKL, and OPG in keratocystic odontogenic tumors, ameloblastomas, and dentigerous cysts.Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 105 3
T. Radics, C. Kiss, I. Tar, I. Márton (2003)
Interleukin-6 and granulocyte-macrophage colony-stimulating factor in apical periodontitis: correlation with clinical and histologic findings of the involved teeth.Oral microbiology and immunology, 18 1
P. Pripatnanont, Y. Song, M. Harris, S. Meghji (2007)
In situ hybridisation and immunocytochemical localisation of osteolytic cytokines and adhesion molecules in ameloblastomas.Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 27 10
L. Armada, P. Marotta, F. Pires, J. Siqueira (2015)
Expression and Distribution of Receptor Activator of Nuclear Factor Kappa B, Receptor Activator of Nuclear Factor Kappa B Ligand, and Osteoprotegerin in Periradicular Cysts.Journal of endodontics, 41 8
Renato Menezes, C. Bramante, Katiúcia Paiva, A. Letra, E. Carneiro, Willian Zambuzzi, J. Granjeiro (2006)
Receptor activator NFkappaB-ligand and osteoprotegerin protein expression in human periapical cysts and granulomas.Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 102 3
Igor Bracks, L. Armada, L. Gonçalves, F. Pires (2014)
Distribution of mast cells and macrophages and expression of interleukin-6 in periapical cysts.Journal of endodontics, 40 1
N. Suzuki, Koyo Takimoto, N. Kawashima (2015)
Cathepsin K Inhibitor Regulates Inflammation and Bone Destruction in Experimentally Induced Rat Periapical Lesions.Journal of endodontics, 41 9
The aim of this study was to investigate the osteoclastogenesis process by means of immunohistochemical markers for receptor activator of nuclear factor κB ligand (RANKL), osteoprotegerin (OPG), interleukin-6 (IL-6), and cathepsin K (CTSK) antigens in osteolytic lesions of maxillary bones. The sample consisted of 23 radicular cysts (RC), 25 odontogenic keratocysts (OKC), and 25 ameloblastomas (AM). RANKL was statistically higher in RC (49.6±15.2/53.7±18) and OKC (48.6±15.1/51.4±16.8) when compared with AM (37.2±12.5/36.4±13) in the epithelium and connective tissue. OPG was lower in OKC (34.8±18.5) only in connective tissue when compared with RC (44.5±11.2). The expression of RANKL was statistically higher than OPG in RC (epithelium and connective tissue) and OKC (connective tissue). For IL-6, a statistical difference was observed only in the connective tissue between groups, with higher expression in RC (48.2±15) and lower in OKC (22±11.9). The expression of IL-6 was correlated with the intensity of the inflammatory infiltrate. CTSK was statistically higher in AM (34±19) and OKC (29±13.8) compared with RC (19±10.5). According to the results of the present research the bone resorption in cysts and odontogenic tumors occurs through different mechanisms. The ostoclastogenic process in lesions with aggressive clinical behavior, as AM and OKC, seems to be associated with the expression of CTSK. In contrast, lesions with inflammatory etiology, as RC, the expression of IL-6 seems to have an important role in the bone resorption process. The highest expression of RANKL under the expression of OPG also seems to contribute to the growth mechanism of RC and OKC.
Applied Immunohistochemistry – Wolters Kluwer Health
Published: May 29, 2021
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.